Skip to content

Exelixis

US · EXEL #1156 by market cap Listed 1970
64.63 -1.20 -1.82%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Price chart

Pre-market 65.85 +0.03%
After-hours 64.63 0.00%
72.7548.5464.632026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on EXEL?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Bullish
  • Recent price momentum is +37.5% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
  • Short interest has fallen to 10.5% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Neutral
  • Price is below its 20-day average and above its 60-day average.
  • The 20-day average is above the 60-day average, a short-term uptrend.
Quant Rating, last 30 days B → C

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2848 U.S. stocks StockVane covers.

Last computed: 2026-11-22 02:27 UTC

Data coverage: 6 of 6 factors. Missing data is not a zero score.

Overall A+
ValuationGrowthProfitMomentumHealthAnalyst
Valuation C+

How expensive the stock is versus earnings, sales and its own 5-year history.

P/E (TTM) 19.4x Better than 44%
Forward P/E 15.9x Better than 52%
Price / Sales 6.3x Better than 17%
P/E vs own 5-yr range 32nd pctl Better than 75%
Growth A

How fast revenue, profit and free cash flow are compounding.

Revenue CAGR (3Y) 12.9% Better than 72%
Net income CAGR (3Y) 62.5% Better than 91%
Free cash flow CAGR (3Y) 55.6% Better than 86%
Profitability A+

How much profit the business keeps from each dollar of sales and capital.

Gross margin 96.4% Better than 98%
Operating margin 38.5% Better than 95%
Net margin 33.7% Better than 93%
Return on equity 35.5% Better than 90%
Return on invested capital 30.4% Better than 96%
Momentum A+

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return 19.5% Better than 96%
6-month return 28.9% Better than 89%
12-month return (ex latest month) 51.8% Better than 84%
Distance below 52-week high 12.3% Better than 78%
Financial Health A

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 3.6x Better than 78%
Debt to assets 6.1% Better than 77%
Interest coverage 19.3x Better than 82%
Free cash flow / net income 107.9% Better than 44%
Analyst View D+

What the Street thinks: share of Buy ratings and upside to the average target.

Analysts rating Buy 57.1% Better than 34%
Upside to average target 0.6% Better than 4%

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W -6.33%
1M +0.37%
3M +20.38%
6M +29.52%
YTD +47.46%
1Y +54.69%
3Y +208.79%
5Y +258.46%

Key statistics

Price & volume

Prev close
65.83
Open
65.95
Day range
64.45 - 66.94
Avg price
65.10
Volume
2.19M
Turnover
142.85M
Amplitude
3.78%
52-week range
39.71 - 73.69

Valuation

P/E
23.25
P/E (TTM)
19.35
P/B
8.60
EPS
2.78
Net profit
678.35M
Net assets
1.83B

Share structure

Market cap
15.77B
Float cap
13.56B
Shares out
244.01M
Float shares
209.78M

Dividend & listing

Dividend (TTM)
0.00
Listing date
1970-01-01
52-week range 73% of range
39.71 73.69

12.3% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-38.01M net over the window

Short interest

Shares short
25.59M
As of
2026-10-30

Frequently asked questions

What is the current stock price of Exelixis (EXEL)?

Exelixis last traded at 64.63. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Exelixis's market cap?

About 15.77B.

What is the P/E ratio of Exelixis?

The trailing twelve-month P/E is 19.35, below its own 5-year average of 27.98 — toward the bottom of its historical range (32.11% percentile). See the Valuation tab for the full history.

Does Exelixis pay a dividend?

Exelixis does not currently pay a regular dividend.

Is Exelixis a buy according to analysts?

The consensus of 7 analysts is a Buy rating, with an average 12-month price target of 65.00, which implies 0.6% upside from the current price. This is not investment advice.

What is Exelixis's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Exelixis a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.

Quote time 2026-11-20 20:02:41 · For reference only, not investment advice and not tailored to your situation.

Exelixis discussion 0 comments

Add a comment